Back to funds

Opaleye Management Inc.

Updated 6 days ago

Managed by Opaleye Management Inc. • Latest filing Q3 2026

Portfolio value
$887.7M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$758M
Q1 2026$759.2M
Q2 2026$1.1B
Q3 2026$887.7M

Top holdings

58 positions as of Q3 2026

View filing
E

ETON PHARMACEUTICALS INC

Value
$125.6M
Shares
2.44M
% Port
14.15%
I

DISC MEDICINE INC

Value
$71.7M
Shares
1.09M
% Port
8.07%
H

HARROW INC

Value
$64.8M
Shares
2.10M
% Port
7.30%
L

LIQUIDIA CORPORATION

Value
$63.8M
Shares
2.11M
% Port
7.19%
U

UROGEN PHARMA LTD

Value
$58.5M
Shares
1.44M
% Port
6.59%
S

SOL-GEL TECHNOLOGIES LTD

Value
$41.2M
Shares
555.0K
% Port
4.64%
M

MEIRAGTX HLDGS PLC

Value
$39.6M
Shares
3.60M
% Port
4.46%
T

TG THERAPEUTICS INC

Value
$31.1M
Shares
557.0K
% Port
3.50%
A

ALPHA COGNITION INC

Value
$29.7M
Shares
3.30M
% Port
3.35%
?
10.N/A

IMMIX BIOPHARMA INC

Value
$29.4M
Shares
2.83M
% Port
3.31%
C

CRESCENT BIOPHARMA INC.

Value
$24M
Shares
1.65M
% Port
2.71%
V

VERASTEM INC

Value
$22.2M
Shares
2.75M
% Port
2.50%
R

REVOLUTION MEDICINES INC

Value
$20.5M
Shares
100.0K
% Port
2.31%
Q

REPLIMUNE GROUP INC

Value
$18.3M
Shares
1.38M
% Port
2.07%
S

STOKE THERAPEUTICS INC

Value
$18M
Shares
692.2K
% Port
2.03%
S

SUMMIT THERAPEUTICS INC

Value
$17.8M
Shares
1.05M
% Port
2.00%
R

REZOLUTE INC

Value
$16.9M
Shares
4.09M
% Port
1.91%
B

BIOHAVEN LTD

Value
$15.9M
Shares
1.19M
% Port
1.79%
P

PROTAGONIST THERAPEUTICS INC

Value
$14.1M
Shares
100.0K
% Port
1.59%
M

MONTE ROSA THERAPEUTICS INC

Value
$12.3M
Shares
1.03M
% Port
1.39%

Explore